Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 20/20 | 0.57 |
| ▸ | ITGA2B | P08514 | 20/20 | 0.57 |
| ▸ | F2R | P25116 | 6/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7498555 | 0.96 | ITGB3 (0.55) | ITGB3ITGA2BF2R | |
| SCHEMBL7504167 | 0.93 | ITGB3 (0.61) | ITGB3ITGA2BF2R | |
| SCHEMBL7500197 | 0.93 | ITGB3 (0.52) | ITGB3ITGA2BF2R | |
| SCHEMBL7501823 | 0.93 | ITGB3 (0.52) | ITGB3ITGA2BF2R | |
| SCHEMBL7446989 | 0.91 | ITGB3 (0.58) | ITGB3ITGA2BF2R | |
| SCHEMBL7504103 | 0.91 | ITGB3 (0.58) | ITGB3ITGA2BF2R | |
| SCHEMBL7496850 | 0.89 | ITGB3 (0.54) | ITGB3ITGA2BF2R | |
| SCHEMBL7505014 | 0.88 | ITGB3 (0.49) | ITGB3ITGA2BF2R | |
| SCHEMBL7818399 | 0.88 | ITGB3 (0.55) | ITGB3ITGA2BF2R | |
| SCHEMBL7507375 | 0.87 | ITGB3 (0.51) | ITGB3ITGA2BF2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6380215-B1 | FOR PREVENTION AND/OR TREATMENT OF DISEASES CAUSED BY THROMBUS FORMATION SUCH AS ARTERIAL THROMBOSIS, ARTERIAL SCLEROSIS, ISCHEMIC HEART DISEASES | FUJISAWA PHARMACEUTICAL CO., LTD (JP) | 2002-04-30 | — | — | US | disclosed |
| EP-0669912-B1 | N-(3-PIPERIDINYLCARBONYL)-BETA-ALANINE DERIVATIVES AS PAF ANTAGONISTS | FUJISAWA PHARMACEUTICAL CO (JP) | 2001-12-05 | — | — | EP | disclosed |
| EP-1106606-A2 | N-(3-piperidinylcarbonyl)-beta-alanine derivatives as paf antagonists | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-06-13 | — | — | EP | disclosed |